Skip to main content

Table 3 Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hemodialysis

From: Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists

Responses about ACEI and ARB on hemodialysis

N = 160

Report that between 30 and 60% of patients on ACEI or ARB

82

CKD5 would not stop ACE I or ARB

98

Would not change ACEI to one that is not dialyzed out

123

Would not stop ACEI or ARB despite hyperkalemia

104